Amber Lee is responsible globally for PPD’s in-country site startup, monitoring and support teams, as well as those for clinical functional service partnerships and centralized monitoring. Lee joined PPD in 2006 and has more than 30 years of experience in operational delivery and has held roles at AstraZeneca, GlaxoSmithKline, Merck, Lipha and Wyeth, as well as academic positions at the University of Southampton, U.K., and the University of Wellington, New Zealand. Om addition, Lee has a wide array of therapeutic experience, including women’s health, circulatory, hematology/oncology, infectious diseases, neuroscience and endocrine/metabolic. Lee earned a Diploma of Clinical Science from the University of Wales and a Bachelor of Nursing from the University of Southampton, U.K. She is a registered general nurse.